| [1] |
YU X D, YAN S S, LIU R J, et al. Apparent differences in prostate zones: Susceptibility to prostate cancer, benign prostatic hyperplasia and prostatitis[J]. Int Urol Nephrol, 2024, 56(8): 2451-2458. doi:10.1007/s11255-024-04012-w .
doi: 10.1007/s11255-024-04012-w
|
| [2] |
王芸, 李萍, 陈璐, 等. 以IKAP理论为指导的延续性护理对老年前列腺癌术后患者尿失禁及生活质量的影响[J]. 护理实践与研究, 2024, 21(1): 125-131. doi:10.3969/j.issn.1672-9676.2024.01.019 .
doi: 10.3969/j.issn.1672-9676.2024.01.019
|
| [3] |
DESTOUNI M, LAZARIS A C, TZELEPI V. Cribriform patterned lesions in the prostate gland with emphasis on differential diagnosis and clinical significance[J]. Cancers, 2022, 14(13): 3041. doi:10.3390/cancers14133041 .
doi: 10.3390/cancers14133041
|
| [4] |
胡博文, 胡亚兰, 梁辉. 前列腺癌早期筛查的常见方法及最新研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(6): 800-808. doi:10.3877/cma.j.issn.1674-3253.2025.06.019 .
doi: 10.3877/cma.j.issn.1674-3253.2025.06.019
|
| [5] |
WANG Y, FENG Y, YANG X, et al. Enhanced transrectal ultrasound, real-time sonoelastography, and contrast-enhanced transrectal ultrasound in heavily prescreened Chinese men with naive and repetitive biopsy: A comparison of detection rate of prostate cancer per man and per lesion[J]. Ultrasound Q, 2022, 38(3): 237-245. doi:10.1097/RUQ.0000000000000589 .
doi: 10.1097/RUQ.0000000000000589
|
| [6] |
FERNANDES M C, YILDIRIM O, WOO S, et al. The role of MRI in prostate cancer: Current and future directions[J]. MAGMA, 2022, 35(4): 503-521. doi:10.1007/s10334-022-01006-6 .
doi: 10.1007/s10334-022-01006-6
|
| [7] |
KAMOI K, OKIHARA K, OCHIAI A, et al. The utility of transrectal real-time elastography in the diagnosis of prostate cancer[J]. Ultrasound Med Biol, 2008, 34(7): 1025-1032. doi:10.1016/j.ultrasmedbio.2007.12.002 .
doi: 10.1016/j.ultrasmedbio.2007.12.002
|
| [8] |
TURKBEY B, ROSENKRANTZ A B, HAIDER M A, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2[J]. Eur Urol, 2019, 76(3): 340-351. doi:10.1016/j.eururo.2019.02.033 .
doi: 10.1016/j.eururo.2019.02.033
|
| [9] |
WILLIAMS I S, MCVEY A, PERERA S, et al. Modern paradigms for prostate cancer detection and management[J]. Med J Aust, 2022, 217(8): 424-433. doi:10.5694/mja2.51722 .
doi: 10.5694/mja2.51722
|
| [10] |
GOURDIN T, VELAYATI A. Treatments and challenges in advanced prostate cancer[J]. Curr Opin Oncol, 2023, 35(3): 200-205. doi:10.1097/CCO.0000000000000938 .
doi: 10.1097/CCO.0000000000000938
|
| [11] |
IPPOLITI S, FLETCHER P, ORECCHIA L, et al. Optimal biopsy approach for detection of clinically significant prostate cancer[J]. Br J Radiol, 2022, 95(1131): 20210413. doi:10.1259/bjr.20210413 .
doi: 10.1259/bjr.20210413
|
| [12] |
张继燊, 谢玉洁, 杨婷, 等. 前列腺特异性膜抗原PET/CT对减少前列腺癌过度穿刺活检的应用价值[J]. 中山大学学报(医学科学版), 2025, 46(2): 311-317. doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2025.0215 .
doi: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2025.0215
|
| [13] |
沈波, 李安域, 朱正, 等. 磁共振/超声成像融合引导的经会阴前列腺穿刺活检对前列腺癌的诊断价值[J]. 转化医学杂志, 2024, 13(10): 1712-1717. doi:10.3639/i.issn.2095-3097. 2024.10.034 .
doi: 10.3639/i.issn.2095-3097. 2024.10.034
|
| [14] |
INOUE T, SHIN T. Current magnetic resonance imaging-based diagnostic strategies for prostate cancer[J]. Int J Urol, 2023, 30(12): 1078-1086. doi:10.1111/iju.15281 .
doi: 10.1111/iju.15281
|
| [15] |
LIU Y, ZENG S, ZHOU D, et al. Diagnostic performance of multiple ultrasonic modalities for prostate cancer[J]. Clinics, 2025, 80: 100680. doi:10.1016/j.clinsp.2025.100680 .
doi: 10.1016/j.clinsp.2025.100680
|
| [16] |
ALMALKI Y E, MANSOUR M G E, ALI S A, et al. Advanced strain elastography is a reliable approach for prostate cancer detection in patients with elevated PSA levels[J]. Sci Rep, 2024, 14: 2917. doi:10.1038/s41598-024-53440-2 .
doi: 10.1038/s41598-024-53440-2
|
| [17] |
LI J, ZHU C, YANG S, et al. Non-invasive diagnosis of prostate cancer and high-grade prostate cancer using multiparametric ultrasonography and serological examination[J]. Ultrasound Med Biol, 2024, 50(4): 600-609. doi:10.1016/j.ultrasmedbio. 2024. 01.003 .
doi: 10.1016/j.ultrasmedbio. 2024. 01.003
|
| [18] |
杨秋子, 毛星刚, 孙季冬, 等. 头颅磁共振成像在轻型颅脑损伤诊断与预后评估中的应用进展[J]. 中华神经外科疾病研究杂志, 2024, 18(6): 90-94.
|
| [19] |
FIARD G, GIGANTI F. How MRI is changing prostate cancer management: A focus on early detection and active surveillance: Comment l’IRM est en train de révolutionner la prise en charge du cancer de la prostate: Focus sur la détection précoce et la surveillance active[J]. Prog Urol, 2022, 32(6S1): 6S19-6S25. doi:10.1016/S1166-7087(22)00171-3 .
doi: 10.1016/S1166-7087(22)00171-3
|
| [20] |
刘玉姗, 徐冉, 曾施, 等. 多种超声模式在前列腺癌诊断中的应用价值比较[J]. 中国临床医学影像杂志, 2023, 34(4): 250-254. doi:10.12117/jccmi.2023.04.006 .
doi: 10.12117/jccmi.2023.04.006
|
| [21] |
NG A B C D, ASIF A, AGARWAL R, et al. Biparametric vs multiparametric MRI for prostate cancer diagnosis: The PRIME diagnostic clinical trial[J]. JAMA, 2025, 334(13): 1170-1179. doi:10.1001/jama.2025.13722 .
doi: 10.1001/jama.2025.13722
|
| [22] |
GREY A D R, SCOTT R, SHAH B, et al. Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): A prospective, multicentre, paired-cohort, confirmatory study[J]. Lancet Oncol, 2022, 23(3): 428-438. doi:10.1016/S1470-2045(22)00016-X .
doi: 10.1016/S1470-2045(22)00016-X
|
| [23] |
张同莉, 王长春, 祖拜热·依斯坎代尔, 等. 经直肠超声造影联合MRI在PSA灰区前列腺癌诊断中的价值[J]. 中国超声医学杂志, 2024, 40(8): 924-927. doi:10.3969/j.issn.1002-0101. 2024.08.027 .
doi: 10.3969/j.issn.1002-0101. 2024.08.027
|
| [24] |
DARYANANI A, TURKBEY B. Recent advancements in CT and MR imaging of prostate cancer[J]. Semin Nucl Med, 2022, 52(3): 365-373. doi:10.1053/j.semnuclmed.2021.11.013 .
doi: 10.1053/j.semnuclmed.2021.11.013
|
| [25] |
DITONNO F, FRANCO A, MANFREDI C, et al. Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: Micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT[J]. Prostate Cancer Prostatic Dis, 2024, 27(1): 29-36. doi:10.1038/s41391-023-00708-9 .
doi: 10.1038/s41391-023-00708-9
|
| [26] |
郭艳娜, 朱益麟, 张萌迪. 经直肠实时组织弹性成像、MRI联合检查参数预测前列腺恶性病变列线图模型的构建及验证[J]. 癌症进展, 2025, 23(17): 2096-2101. doi:10.11877/j.issn.1672-1535.2025.23.17.26 .
doi: 10.11877/j.issn.1672-1535.2025.23.17.26
|
| [27] |
SINGH D, CHANDRAN A, PANEBIANCO V, et al. MRI capacity assessment for prostate cancer screening in five sites of Europe[J]. Eur J Radiol, 2025, 190: 112235. doi:10.1016/j.ejrad. 2025.112235 .
doi: 10.1016/j.ejrad. 2025.112235
|